Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMIYAMOTO, Denise
dc.contributor.authorSANTI, Claudia Giuli
dc.contributor.authorMARUTA, Celina Wakisaka
dc.contributor.authorAOKI, Valeria
dc.date.accessioned2022-06-20T15:26:34Z
dc.date.available2022-06-20T15:26:34Z
dc.date.issued2022
dc.description.abstractAutoimmune blistering diseases comprise a rare group of potentially life-threatening dermatoses. Management of autoimmune disorders poses a challenge in terms of achieving disease control and preventing adverse events. Treatment often requires an individualized approach considering disease severity, age, comorbidities, and infectious risk especially in the context of the ongoing COVID-19 pandemic. Knowledge regarding SARS-CoV-2 infection is still evolving and no specific antiviral therapy is available yet. We report four patients with active disease that required adjustment of treatment during the pandemic to discuss the use of immunosuppressants and immunobiologics, weighing potential risks and benefits of each therapy modality and vaccination status.eng
dc.description.indexPubMedeng
dc.identifier.citationFRONTIERS IN MEDICINE, v.8, article ID 811562, 6p, 2022
dc.identifier.doi10.3389/fmed.2021.811562
dc.identifier.eissn2296-858X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/47093
dc.language.isoeng
dc.publisherFRONTIERS MEDIA SAeng
dc.relation.ispartofFrontiers in Medicine
dc.rightsopenAccesseng
dc.rights.holderCopyright FRONTIERS MEDIA SAeng
dc.subjectCOVID-19eng
dc.subjectSARS-CoV-2eng
dc.subjectautoimmune blistering diseaseseng
dc.subjectpemphiguseng
dc.subjectimmunosuppressantseng
dc.subjectrituximabeng
dc.subjectvaccineeng
dc.subject.otherpemphiguseng
dc.subject.othertherapyeng
dc.subject.wosCardiac & Cardiovascular Systemseng
dc.titleConsiderations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Reporteng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcDENISE MIYAMOTO
hcfmusp.contributor.author-fmusphcCLAUDIA GIULI SANTI
hcfmusp.contributor.author-fmusphcCELINA WAKISAKA MARUTA
hcfmusp.contributor.author-fmusphcVALERIA AOKI
hcfmusp.description.articlenumber811562
hcfmusp.description.volume8
hcfmusp.origemWOS
hcfmusp.origem.pubmed35495200
hcfmusp.origem.scopus2-s2.0-85128760316
hcfmusp.origem.wosWOS:000791829000001
hcfmusp.publisher.cityLAUSANNEeng
hcfmusp.publisher.countrySWITZERLANDeng
hcfmusp.relation.referenceAnuragi RP, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14361eng
hcfmusp.relation.referenceAvancini J, 2021, J AM ACAD DERMATOL, V84, pE67, DOI 10.1016/j.jaad.2020.09.030eng
hcfmusp.relation.referenceCozzani E, 2021, EUR J DERMATOL, V31, P415, DOI 10.1684/ejd.2021.4043eng
hcfmusp.relation.referenceCugno M, 2016, THROMB HAEMOSTASIS, V115, P193, DOI 10.1160/TH15-04-0309eng
hcfmusp.relation.referenceDamiani G, 2021, J EUR ACAD DERMATOL, V35, pE645, DOI 10.1111/jdv.17472eng
hcfmusp.relation.referenceDong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1eng
hcfmusp.relation.referenceDrenovska K, 2021, CLIN DERMATOL, V39, P359, DOI 10.1016/j.clindermatol.2021.01.007eng
hcfmusp.relation.referenceGambichler T, 2022, BRIT J DERMATOL, V186, P728, DOI 10.1111/bjd.20890eng
hcfmusp.relation.referenceHanan N, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060596eng
hcfmusp.relation.referenceHorby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]eng
hcfmusp.relation.referenceHwang E, 2021, BRIT J DERMATOL, V185, P1048, DOI 10.1111/bjd.20571eng
hcfmusp.relation.referenceKasperkiewicz M, 2021, J EUR ACAD DERMATOL, V35, pE412, DOI 10.1111/jdv.17207eng
hcfmusp.relation.referenceKasperkiewicz M, 2021, J AM ACAD DERMATOL, V84, P563, DOI 10.1016/j.jaad.2020.08.012eng
hcfmusp.relation.referenceKato F, 2020, MICROBIOL IMMUNOL, V64, P635, DOI 10.1111/1348-0421.12828eng
hcfmusp.relation.referenceKridin K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01559eng
hcfmusp.relation.referenceKridin K, 2018, J DERMATOL, V45, P1094, DOI 10.1111/1346-8138.14503eng
hcfmusp.relation.referenceLorenz Camila, 2021, Rev. bras. epidemiol., V24, pe210040, DOI 10.1590/1980-549720210040eng
hcfmusp.relation.referenceMahmoudi H, 2021, J AM ACAD DERMATOL, V84, P1098, DOI 10.1016/j.jaad.2020.12.043eng
hcfmusp.relation.referenceMoor MB, 2021, LANCET RHEUMATOL, V3, pE789, DOI 10.1016/S2665-9913(21)00251-4eng
hcfmusp.relation.referenceMurrell DF, 2020, J AM ACAD DERMATOL, V82, P575, DOI 10.1016/j.jaad.2018.02.021eng
hcfmusp.relation.referenceNegri EM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.573044eng
hcfmusp.relation.referenceShakshouk H, 2021, J AM ACAD DERMATOL, V84, pE61, DOI 10.1016/j.jaad.2020.09.002eng
hcfmusp.relation.referenceSokumbi O, 2013, J AM ACAD DERMATOL, V68, P36, DOI 10.1016/j.jaad.2012.07.003eng
hcfmusp.relation.referenceSolimani F, 2021, J EUR ACAD DERMATOL, V35, pE649, DOI 10.1111/jdv.17480eng
hcfmusp.relation.referenceStrangfeld A, 2021, ANN RHEUM DIS, V80, P930, DOI 10.1136/annrheumdis-2020-219498eng
hcfmusp.relation.referenceSun QS, 2021, DERMATOL CLIN, V39, P639, DOI 10.1016/j.det.2021.05.014eng
hcfmusp.relation.referenceThompson AE, 2020, JAMA INTERN MED, V180, P1537, DOI 10.1001/jamainternmed.2020.3030eng
hcfmusp.relation.referenceVijenthira A, 2021, BLOOD ADV, V5, P2624, DOI 10.1182/bloodadvances.2021004629eng
hcfmusp.relation.referenceWack S, 2021, J AM ACAD DERMATOL, V85, P1274, DOI 10.1016/j.jaad.2021.07.054eng
hcfmusp.relation.referenceZwerner J, 2007, DERMATOL THER, V20, P229, DOI 10.1111/j.1529-8019.2007.00136.xeng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication9298564f-de32-4534-a058-e59872735de2
relation.isAuthorOfPublication95eafa3a-94ea-4de1-ba37-426c1b6f1f61
relation.isAuthorOfPublication2af23e04-c9af-4f35-bd14-4c93e9831d29
relation.isAuthorOfPublication39977d9c-4d58-4ad3-9df5-f4625a05e3b3
relation.isAuthorOfPublication.latestForDiscovery9298564f-de32-4534-a058-e59872735de2
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_MIYAMOTO_Considerations_on_Immunization_and_Immunosuppression_of_Patients_With_2022.PDF
Tamanho:
916.25 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/53
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - ODS/03
Carregar mais